Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A Randomized Clinical Trial to Evaluate the Single-dose Pharmacokinetics, Pharmacodynamics and Safety of Sitagliptin in Pediatric Patients with Type 2 Diabetes.

Fraser IP, Neufeld ND, Fox LA, Kipnes MS, Miller TL, Zeitler PS, Rodriguez H, Gilmartin JH, Lee SJ, Patterson JK, Li XS, Maganti L, Luo WL, Tatosian DA, Aubrey Stoch S.

Pediatr Diabetes. 2018 Oct 22. doi: 10.1111/pedi.12790. [Epub ahead of print]

PMID:
30346099
2.

Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators.

Clapper JR, Henry CL, Niphakis MJ, Knize AM, Coppola AR, Simon GM, Ngo N, Herbst RA, Herbst DM, Reed AW, Cisar JS, Weber OD, Viader A, Alexander JP, Cunningham ML, Jones TK, Fraser IP, Grice CA, Ezekowitz RAB, O'Neill GP, Blankman JL.

J Pharmacol Exp Ther. 2018 Oct 10. pii: jpet.118.252296. doi: 10.1124/jpet.118.252296. [Epub ahead of print]

3.

Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3.

Yeh WW, Fraser IP, Jumes P, Petry A, Lepeleire I, Robberechts M, Reitmann C, Van Dyck K, Huang X, Guo Z, Panebianco D, Nachbar RB, O'Mara E, Wagner JA, Butterton JR, Dutko FJ, Moiseev V, Kobalava Z, Hüser A, Visan S, Schwabe C, Gane E, Popa S, Ghicavii N, Uhle M, Wagner F.

Clin Ther. 2018 May;40(5):704-718.e6. doi: 10.1016/j.clinthera.2018.03.002. Epub 2018 Apr 25.

PMID:
29703432
4.

Effect of Hepatic Impairment on the Pharmacokinetics of Grazoprevir, a Hepatitis C Virus Protease Inhibitor.

Caro L, Wenning L, Guo Z, Fraser IP, Fandozzi C, Talaty J, Panebianco D, Ho M, Uemura N, Reitmann C, Angus P, Gane E, Marbury T, Smith WB, Iwamoto M, Butterton JR, Yeh WW.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00813-17. doi: 10.1128/AAC.00813-17. Print 2017 Dec.

5.

Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.

Prueksaritanont T, Chu X, Evers R, Klopfer SO, Caro L, Kothare PA, Dempsey C, Rasmussen S, Houle R, Chan G, Cai X, Valesky R, Fraser IP, Stoch SA.

Br J Clin Pharmacol. 2014 Sep;78(3):587-98. doi: 10.1111/bcp.12377.

6.

Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.

Fraser IP, Han L, Han TH, Li CC, Hreniuk D, Stoch SA, Wagner JA, Linder S, Winner P.

Headache. 2012 Apr;52(4):625-35. doi: 10.1111/j.1526-4610.2011.02069.x. Epub 2012 Jan 30.

PMID:
22289113
7.

Effect of different durations and formulations of diltiazem on the single-dose pharmacokinetics of midazolam: how long do we go?

Friedman EJ, Fraser IP, Wang YH, Bergman AJ, Li CC, Larson PJ, Chodakewitz J, Wagner JA, Stoch SA.

J Clin Pharmacol. 2011 Nov;51(11):1561-70. doi: 10.1177/0091270010387141. Epub 2011 Jan 5.

PMID:
21209240
8.

Suppurative lymphadenitis.

Fraser IP.

Curr Infect Dis Rep. 2009 Sep;11(5):383-8.

PMID:
19698282
9.

Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone.

Ito T, Fraser IP, Yeo Y, Highley CB, Bellas E, Kohane DS.

Biomaterials. 2007 Apr;28(10):1778-86. Epub 2007 Jan 3.

PMID:
17204321
10.

Case records of the Massachusetts General Hospital. Case 32-2006. A 3-year-old girl with fever after a visit to Africa.

Fraser IP, Cserti CM, Dzik WH.

N Engl J Med. 2006 Oct 19;355(16):1715-22. No abstract available.

PMID:
17050896
11.

Netrin-1 inhibits leukocyte migration in vitro and in vivo.

Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB.

Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14729-34. Epub 2005 Oct 3.

12.

Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity.

Cho JH, Fraser IP, Fukase K, Kusumoto S, Fujimoto Y, Stahl GL, Ezekowitz RA.

Blood. 2005 Oct 1;106(7):2551-8. Epub 2005 Jun 14.

13.

TLR-independent pattern recognition receptors and anti-inflammatory mechanisms.

Fraser IP, Stuart L, Ezekowitz RA.

J Endotoxin Res. 2004;10(2):120-4. Review.

PMID:
15120003
14.

Pneumocystis carinii enhances soluble mannose receptor production by macrophages.

Fraser IP, Takahashi K, Koziel H, Fardin B, Harmsen A, Ezekowitz RA.

Microbes Infect. 2000 Sep;2(11):1305-10.

PMID:
11018446
15.
17.

Cytokine and growth factor regulation of macrophage scavenger receptor expression and function.

de Villiers WJ, Fraser IP, Gordon S.

Immunol Lett. 1994 Dec;43(1-2):73-9. Review.

PMID:
7737693
18.

Murine M phi scavenger receptor: adhesion function and expression.

Hughes DA, Fraser IP, Gordon S.

Immunol Lett. 1994 Dec;43(1-2):7-14.

PMID:
7737692
19.

Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function.

de Villiers WJ, Fraser IP, Hughes DA, Doyle AG, Gordon S.

J Exp Med. 1994 Aug 1;180(2):705-9.

20.

Supplemental Content

Loading ...
Support Center